Table 2.
Critical trials |
Filler trials |
|||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|
Conditions | CC |
CA |
AA |
AC |
RU |
UR |
||||||
Endorsed ADJ | 1st ADJ | 2nd ADJ | 1st ADJ | 2nd ADJ | 1st ADJ | 2nd ADJ | 1st ADJ | 2nd ADJ | 1st ADJ | 2nd ADJ | 1st ADJ | 2nd ADJ |
LVF/RH nouns (%) | 47 | 53 | 55 | 45 | 46 | 54 | 53 | 47 | 78 | 22 | 22 | 78 |
RVF/LH nouns (%) | 48 | 52 | 54 | 46 | 45 | 55 | 51 | 49 | 87 | 13 | 17 | 83 |